Canada Life’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-38,780
| Closed | -$365K | – | 2688 |
|
|
2020
Q3 | $365K | Sell |
38,780
-5,914
| -13% | -$56.2K | ﹤0.01% | 1762 |
|
|
2020
Q2 | $342K | Buy |
44,694
+4,279
| +11% | +$32.7K | ﹤0.01% | 1779 |
|
|
2020
Q1 | $249K | Hold |
40,415
| – | – | ﹤0.01% | 1771 |
|
|
2019
Q4 | $488K | Buy |
+40,415
| New | +$442K | ﹤0.01% | 1720 |
|
|
2019
Q3 | – | Sell |
-48,184
| Closed | -$481K | – | 2626 |
|
|
2019
Q2 | $481K | Hold |
48,184
| – | – | ﹤0.01% | 1781 |
|
|
2019
Q1 | $620K | Buy |
48,184
+3,260
| +7% | +$48.5K | ﹤0.01% | 1568 |
|
|
2018
Q4 | $629K | Buy |
44,924
+4,919
| +12% | +$93.7K | ﹤0.01% | 1589 |
|
|
2018
Q3 | $800K | Sell |
40,005
-5,014
| -11% | -$114K | ﹤0.01% | 1613 |
|
|
2018
Q2 | $875K | Hold |
45,019
| – | – | ﹤0.01% | 1575 |
|
|
2018
Q1 | $906K | Hold |
45,019
| – | – | ﹤0.01% | 1545 |
|
|
2017
Q4 | $594K | Sell |
45,019
-3,927
| -8% | -$59.2K | ﹤0.01% | 1686 |
|
|
2017
Q3 | $869K | Hold |
48,946
| – | – | ﹤0.01% | 1560 |
|
|
2017
Q2 | $898K | Buy |
48,946
+2,200
| +5% | +$43.6K | ﹤0.01% | 1554 |
|
|
2017
Q1 | $1.05M | Buy |
46,746
+1,724
| +4% | +$41.3K | ﹤0.01% | 1491 |
|
|
2016
Q4 | $1.56M | Hold |
45,022
| – | – | ﹤0.01% | 1243 |
|
|
2016
Q3 | $1.1M | Hold |
45,022
| – | – | ﹤0.01% | 1401 |
|
|
2016
Q2 | $1.08M | Buy |
45,022
+41,969
| +1,375% | +$962K | ﹤0.01% | 1374 |
|
|
2016
Q1 | $71K | Hold |
3,053
| – | – | ﹤0.01% | 1987 |
|
|
2015
Q4 | $92K | Hold |
3,053
| – | – | ﹤0.01% | 1820 |
|
|
2015
Q3 | $122K | Sell |
3,053
-20,500
| -87% | -$1.27M | ﹤0.01% | 1566 |
|
|
2015
Q2 | $1.62M | Buy |
23,553
+22,100
| +1,521% | +$1.39M | 0.01% | 843 |
|
|
2015
Q1 | $79K | Hold |
1,453
| – | – | ﹤0.01% | 1931 |
|
|
2014
Q4 | $62K | Sell |
1,453
-2,300
| -61% | -$83.1K | ﹤0.01% | 2008 |
|
|
2014
Q3 | $120K | Buy |
+3,753
| New | +$80K | ﹤0.01% | 1550 |
|
Canada Life's AMAG Position: Q4 2020 in Review
Canada Life sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 38,780 shares — an estimated $365K sold.
Canada Life first reported a position in AMAG in Q3 2014 and held it in 24 quarters. The position peaked at $1.62M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Canada Life reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Canada Life sold 38,780 AMAG Pharmaceuticals shares in Q4 2020, an estimated $365K.
- Canada Life first reported a position in AMAG Pharmaceuticals in Q3 2014 and held it in 24 quarters.
- Canada Life's AMAG Pharmaceuticals position peaked at $1.62M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Canada Life's 13F filing for Q4 2020, filed 16 Feb 2021.